135 related articles for article (PubMed ID: 37936787)
61. Asymptomatic and mild beta-thalassemia in homozygotes and compound heterozygotes for the IVS2+1G-->A mutation: role of the beta-globin gene haplotype.
Ragusa A; Amata S; Lombardo T; Castiglia L; Maier-Redelsperger M; Labie D; Bernini L
Haematologica; 2003 Oct; 88(10):1099-105. PubMed ID: 14555304
[TBL] [Abstract][Full Text] [Related]
62. Molecular understanding of unusual HbE-β
Jomoui W; Satthakarn S; Panyasai S
Ann Med; 2023; 55(2):2267054. PubMed ID: 37816374
[TBL] [Abstract][Full Text] [Related]
63. Annotated definition of BCL11A and HMIP-2 haplotypes through the analysis of sicilian β-thalassemia patients with high levels of fetal hemoglobin.
Buccheri MA; Spina S; Ruberto C; Lombardo T; Labie D; Ragusa AA
Hemoglobin; 2013; 37(5):423-34. PubMed ID: 23777413
[TBL] [Abstract][Full Text] [Related]
64. The rs61742690 (S783N) single nucleotide polymorphism is a suitable target for disrupting BCL11A-mediated foetal-to-adult globin switching.
Abdulazeez S; Sultana S; Almandil NB; Almohazey D; Bency BJ; Borgio JF
PLoS One; 2019; 14(2):e0212492. PubMed ID: 30768627
[TBL] [Abstract][Full Text] [Related]
65. Estimation of the difference in HbF expression due to loss of the 5' δ-globin BCL11A binding region.
Ghedira ES; Lecerf L; Faubert E; Costes B; Moradkhani K; Bachir D; Galactéros F; Pissard S
Haematologica; 2013 Feb; 98(2):305-8. PubMed ID: 22801970
[TBL] [Abstract][Full Text] [Related]
66. Molecular basis of β-thalassemia in the United Arab Emirates.
Baysal E
Hemoglobin; 2011; 35(5-6):581-8. PubMed ID: 22074124
[TBL] [Abstract][Full Text] [Related]
67. Detection of BCL11A and HBS1L-MYB Genotypes in Sickle Cell Anemia.
Qadah T; Noorwali A; Alzahrani F; Banjar A; Filimban N; Felimban R
Indian J Hematol Blood Transfus; 2020 Oct; 36(4):705-710. PubMed ID: 33100714
[TBL] [Abstract][Full Text] [Related]
68. Prevalence and Impact of HMOX1 Polymorphism (rs2071746: A > T) in Indian Sickle Cell Disease Patients.
Pandey H; Singh K; Ranjan R; Dass J; Tyagi S; Seth T; Saxena R; Mahapatra M
J Lab Physicians; 2023 Dec; 15(4):583-589. PubMed ID: 37780888
[No Abstract] [Full Text] [Related]
69. Spectrum of β-thalassemia mutations in the eastern province of Saudi Arabia.
Al-Sultan A; Phanasgaonkar S; Suliman A; Al-Baqushi M; Nasrullah Z; Al-Ali A
Hemoglobin; 2011; 35(2):125-34. PubMed ID: 21417569
[TBL] [Abstract][Full Text] [Related]
70. The Genetic and Clinical Significance of Fetal Hemoglobin Expression in Sickle Cell Disease.
Adekile A
Med Princ Pract; 2021; 30(3):201-211. PubMed ID: 32892201
[TBL] [Abstract][Full Text] [Related]
71. Correlations between Multiple SNPs and HbF Levels in β-Thalassemia Carriers.
Xu Q; Huang L; Jin T; Han Y; Liu J; Zhang W; Biao Y; An B; Huang S
Clin Lab; 2023 Sep; 69(9):. PubMed ID: 37702677
[TBL] [Abstract][Full Text] [Related]
72. Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
Sales RR; Belisário AR; Faria G; Mendes F; Luizon MR; Viana MB
Ann Hematol; 2020 Jul; 99(7):1453-1463. PubMed ID: 32447424
[TBL] [Abstract][Full Text] [Related]
73. Beta zero and beta+ thalassemia genes in northern Greece.
Koliakos GG; Dimitriadou-Vaphiadou A; Christakis J; Trakatellis A
Gene Geogr; 1991; 5(1-2):55-60. PubMed ID: 1820156
[TBL] [Abstract][Full Text] [Related]
74. The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival.
Rumaney MB; Ngo Bitoungui VJ; Vorster AA; Ramesar R; Kengne AP; Ngogang J; Wonkam A
PLoS One; 2014; 9(6):e100516. PubMed ID: 24978191
[TBL] [Abstract][Full Text] [Related]
75. rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.
Chaouch L; Moumni I; Ouragini H; Darragi I; Kalai M; Chaouachi D; Boudrigua I; Hafsia R; Abbes S
Hematology; 2016 Aug; 21(7):425-9. PubMed ID: 27077760
[TBL] [Abstract][Full Text] [Related]
76. miR-365-3p mediates BCL11A and SOX6 erythroid-specific coregulation: A new player in HbF activation.
Simbula M; Manchinu MF; Mingoia M; Pala M; Asunis I; Caria CA; Perseu L; Shah M; Crossley M; Moi P; Ristaldi MS
Mol Ther Nucleic Acids; 2023 Dec; 34():102025. PubMed ID: 37744176
[TBL] [Abstract][Full Text] [Related]
77. Targeting fetal hemoglobin expression to treat β hemoglobinopathies.
Steinberg MH
Expert Opin Ther Targets; 2022 Apr; 26(4):347-359. PubMed ID: 35418266
[TBL] [Abstract][Full Text] [Related]
78. Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia.
Gueye Tall F; Martin C; Ndour EHM; Renoux C; Ly ID; Connes P; Gueye PM; Diallo RN; Diagne I; Diop PA; Cissé A; Lopez Sall P; Joly P
Pediatr Blood Cancer; 2019 Oct; 66(10):e27934. PubMed ID: 31322815
[TBL] [Abstract][Full Text] [Related]
79. Clinical and laboratory features of sickle cell disease in The Netherlands.
Aluoch JR; De Geus A; Goudsmit R
Trop Geogr Med; 1988 Jan; 40(1):7-12. PubMed ID: 3381319
[TBL] [Abstract][Full Text] [Related]
80. β-Globin Gene Mutations in Pediatric Patients with β-Thalassemia in the Region of Çukurova, Turkey.
Guzelgul F; Seydel GS; Aksoy K
Hemoglobin; 2020 Jul; 44(4):249-253. PubMed ID: 32664780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
